Top Health Care Reform Stories
Amgen spent $2.82 million on lobbying in 3Q
By Associated PressBiotech drugmaker Amgen Inc. spent $2.82 million lobbying the federal government during the third quarter, focusing its efforts on health care and prescription drug issues.
